Troluce Capital Advisors »

Cytokinetics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $11M 214k 52.80
2024-06-30 $7.1M 130k 54.18
2024-03-31 $12M 175k 70.11

More positions owned by Troluce Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Tko Group Holdings Cl A (TKO)
Summit Matls Cl A Put Option (SUM)
Select Sector Spdr Tr Indl Put Option (XLI)
Smurfit Westrock SHS
Live Nation Entertainment Put Option (LYV)
Western Digital Call Option (WDC)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Flutter Entmt SHS Call Option (FLUT)
Vistra Energy Put Option (VST)
Siriusxm Holdings Common Stock Call Option
Select Sector Spdr Tr Sbi Materials Put Option (XLB)
Roivant Sciences SHS (ROIV)
Capri Holdings SHS (CPRI)

View all positions for Troluce Capital Advisors

Top funds holding Cytokinetics

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Bank of America Corporation
T. Rowe Price Associates
Armistice Capital
Geode Capital Management
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Alliancebernstein
Marshall Wace
Partner Fund Management

View all funds holding Cytokinetics